# Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section

> **NCT04780412** · PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 210 (actual)

## Conditions studied

- Transient Tachypnea of the Newborn
- Neonatal Respiratory Distress

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04780412
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780412, "Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04780412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*